Stocks and Investing
Stocks and Investing
Wed, April 10, 2019
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, April 9, 2019
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
John Newman Maintained (ALRN) at Strong Buy with Decreased Target to $100 on, Apr 9th, 2019
John Newman of Canaccord Genuity, Maintained "Aileron Therapeutics, Inc." (ALRN) at Strong Buy with Decreased Target from $380 to $100 on, Apr 9th, 2019.
John has made no other calls on ALRN in the last 4 months.
There is 1 other peer that has a rating on ALRN. Out of the 1 peers that are also analyzing ALRN, 0 agree with John's Rating of Hold.
This is the rating of the analyst that currently disagrees with John
- Edward White of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $140 on, Monday, March 11th, 2019